Biden is look­ing be­yond Wood­cock or Sharf­stein for FDA com­mis­sion­er — re­port

Nei­ther Janet Wood­cock nor Joshua Sharf­stein is like­ly to be nom­i­nat­ed as the per­ma­nent FDA com­mis­sion­er, Steve Us­din at Bio­Cen­tu­ry re­ports.

The White House is look­ing for al­ter­na­tives to Wood­cock, the act­ing chief and long­time CDER di­rec­tor, af­ter op­po­si­tion from sev­er­al De­mo­c­ra­t­ic sen­a­tors who are call­ing on oth­ers to block her nom­i­na­tion if her name is put forth, ac­cord­ing to Us­din. Sharf­stein, the for­mer prin­ci­pal deputy FDA com­mis­sion­er and cur­rent Johns Hop­kins pro­fes­sor, is out of the run­ning al­to­geth­er.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER